$0.32
25.82%
Nasdaq, Sep 24, 04:28 pm EDT.
ISIN
US0390142042
Symbol
RKDA

Arcadia Biosciences, Inc. Stock price

$0.32
-0.16 34.24% 1M
-1.38 81.41% 6M
-1.66 84.04% YTD
-3.29 91.25% 1Y
-3.09 90.73% 3Y
-82.00 99.62% 5Y
-1,566.12 99.98% 10Y
-5,833.85 99.99% 20Y
Nasdaq, Closing price Thu, Sep 24 2026
-0.11 25.82%
ISIN
US0390142042
Symbol
RKDA
Industry

Is Arcadia Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$760.0k
Enterprise Value
$-3.4m
Net debt
positive
Cash
$4.2m
Shares outstanding
2.2m
Valuation (TTM | estimate)
P/E
negative
P/S
0.2 | 0.1
EV/Sales
negative | negative
EV/FCF
1.3
P/B
1.2
Financial Health
Equity Ratio
63.2%
Return on Equity
-56.5%
ROCE
-89.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$4.8m | $7.9m
EBITDA
$-3.8m
EBIT
$-3.8m
Net Income
$-11.1m
Free Cash Flow
$-2.5m
Growth (TTM | estimate)
Revenue
-12.2% | 61.6%
EBITDA
16.7%
EBIT
17.5%
Net Income
-47.6%
Free Cash Flow
66.5%
Margin
Gross
34.6%
EBITDA
-79.9%
EBIT
-80.1%
Net
-234.5%
Free Cash Flow
-53.4%
More
EPS
$-3.7
FCF per Share
$-1.2
Short interest
0.8%
Employees
8
Rev per Employee
$610.0k

Arcadia Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Arcadia Biosciences, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Arcadia Biosciences, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Arcadia Biosciences, Inc.

Jun '26
+/-
%
4.75 4.75
12% 12%
100%
- Direct Costs 3.11 3.11
3% 3%
65%
1.64 1.64
25% 25%
35%
- Selling and Administrative Expenses 5.44 5.44
38% 38%
115%
- Research and Development Expense - -
-
-
-3.79 -3.79
17% 17%
-80%
- Depreciation and Amortization 0.01 0.01
83% 83%
0%
EBIT (Operating Income) EBIT -3.80 -3.80
17% 17%
-80%
Net Profit -11 -11
48% 48%
-234%

In millions USD.

Don't miss a Thing! We will send you all news about Arcadia Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arcadia Biosciences, Inc. Stock News

Neutral
GlobeNewsWire
●
about one month ago
– Net cash used in operating activities only $319K in the second quarter – – Arcadia closes $4 million private placement; ends second quarter with $4.2 million in cash – – July monthly Zola ® sales top $740K; exceed $1 million through first week of August – DALLAS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness produc...
Neutral
GlobeNewsWire
●
3 months ago
DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment o...
Neutral
GlobeNewsWire
●
4 months ago
DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of ...
More Arcadia Biosciences, Inc. News

Company Profile

Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. The company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Head office United States
CEO Mr. Schaefer
Employees 8
Founded 2002
Website arcadiabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today